Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Genpharmasec Ltd · Outcome · 03 Nov 2026, 10:55 pm
Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 8,566 (+162.5% YoY | +72.3% QoQ) ■ EBITDA: 164 (Loss to Profit YoY | +71.4% QoQ) ■ EBITDA Margin (%): 1.9 (Loss to Profit YoY | -1 bps QoQ) ■ PAT: 125 (Loss to Profit YoY | +381.9% QoQ) ■ EPS (INR): 0.01 (Loss to Profit YoY) Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Pharmaceutical Trading ■ Revenue: 8,155 (+165.5% YoY | +73.5% QoQ) ■ EBIT: 282 (+93.3% YoY | +28.2% QoQ) ■ EBIT Margin (%): 3.5 (-129 bps YoY | -122 bps QoQ) Laboratory Testing ■ Revenue: 0.0 (-100.0% YoY) ■ EBIT: -39.9 (-6.3% YoY | -36.7% QoQ) ■ EBIT Margin (%): 0.0 (Loss to Profit YoY) Manufacturing & Processing ■ Revenue: 411 (+172.5% YoY | +51.3% QoQ) ■ EBIT: -40.0 (+75.8% YoY | +68.0% QoQ) ■ EBIT Margin (%): -9.7 (+9981 bps YoY | +3627 bps QoQ)
Original exchange filing (PDF)
More announcements from Genpharmasec Ltd
- Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September, 2026. · 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. · 03 Nov 2026
- Unaudited Standalone & consolidated Financial Result of the company for the quarter & half year ended 30th September 2026. · 03 Nov 2026
- Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... · 03 Nov 2026
- Intimation under regulation 30 - Change of name of Subsidiary of the company. · 14 Oct 2026
- Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026. · 30 Sept 2026
- Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026. · 29 Sept 2026
- Annual Report for Financial Year 2025-26. · 07 Sept 2026
